 Robert Lyle
Concepts (109)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ductus Arteriosus, Patent | 2 | 2019 | 38 | 0.300 |
Why?
| | DNA | 1 | 2010 | 536 | 0.270 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2018 | 124 | 0.260 |
Why?
| | Asthma | 1 | 2010 | 303 | 0.250 |
Why?
| | Infant, Premature | 4 | 2019 | 316 | 0.210 |
Why?
| | Medicaid | 2 | 2018 | 258 | 0.200 |
Why?
| | Disabled Children | 2 | 2013 | 62 | 0.180 |
Why?
| | Infant, Newborn | 7 | 2019 | 2760 | 0.170 |
Why?
| | Hospitalization | 2 | 2017 | 678 | 0.160 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2019 | 8 | 0.160 |
Why?
| | Chronic Disease | 3 | 2011 | 576 | 0.160 |
Why?
| | Health Care Costs | 2 | 2018 | 172 | 0.150 |
Why?
| | Child, Preschool | 7 | 2018 | 3966 | 0.150 |
Why?
| | Infant, Low Birth Weight | 1 | 2018 | 75 | 0.150 |
Why?
| | Continuity of Patient Care | 1 | 2018 | 52 | 0.140 |
Why?
| | Clinical Protocols | 1 | 2017 | 111 | 0.130 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2016 | 19 | 0.130 |
Why?
| | Hypoglycemia | 1 | 2016 | 55 | 0.130 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 93 | 0.130 |
Why?
| | DNA Copy Number Variations | 2 | 2016 | 109 | 0.120 |
Why?
| | Child | 8 | 2018 | 6979 | 0.120 |
Why?
| | Developmental Disabilities | 1 | 2016 | 120 | 0.120 |
Why?
| | Hospitals, Pediatric | 3 | 2013 | 234 | 0.110 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 489 | 0.110 |
Why?
| | Comprehensive Health Care | 1 | 2013 | 9 | 0.110 |
Why?
| | Infant | 6 | 2018 | 3660 | 0.100 |
Why?
| | Blood Cells | 1 | 2012 | 47 | 0.090 |
Why?
| | Genome, Human | 1 | 2012 | 109 | 0.090 |
Why?
| | Child, Exceptional | 1 | 2011 | 5 | 0.090 |
Why?
| | Cost Savings | 1 | 2011 | 58 | 0.090 |
Why?
| | Parents | 1 | 2013 | 323 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2018 | 2246 | 0.080 |
Why?
| | Fetal Blood | 1 | 2010 | 66 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2010 | 135 | 0.080 |
Why?
| | Genetic Association Studies | 1 | 2010 | 119 | 0.080 |
Why?
| | Longitudinal Studies | 3 | 2018 | 733 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2013 | 492 | 0.080 |
Why?
| | Patient Care Team | 1 | 2011 | 259 | 0.080 |
Why?
| | Humans | 13 | 2022 | 50688 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2011 | 243 | 0.080 |
Why?
| | Time Factors | 2 | 2018 | 2948 | 0.080 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2009 | 34 | 0.080 |
Why?
| | Genotype | 1 | 2010 | 532 | 0.080 |
Why?
| | Child Health Services | 1 | 2009 | 78 | 0.070 |
Why?
| | Home Care Services | 1 | 2009 | 73 | 0.070 |
Why?
| | Female | 8 | 2018 | 27188 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2010 | 474 | 0.070 |
Why?
| | Male | 7 | 2018 | 25998 | 0.070 |
Why?
| | DNA Methylation | 1 | 2010 | 549 | 0.060 |
Why?
| | Cohort Studies | 3 | 2018 | 1456 | 0.060 |
Why?
| | Patient Discharge | 2 | 2018 | 319 | 0.060 |
Why?
| | Prospective Studies | 1 | 2010 | 2395 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2022 | 643 | 0.050 |
Why?
| | Embryonic Stem Cells | 1 | 2022 | 15 | 0.050 |
Why?
| | Age Factors | 2 | 2018 | 1120 | 0.050 |
Why?
| | Adolescent | 3 | 2018 | 6489 | 0.050 |
Why?
| | Acetylcysteine | 1 | 2002 | 101 | 0.050 |
Why?
| | Peptide Hydrolases | 1 | 2002 | 61 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2002 | 117 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2002 | 116 | 0.040 |
Why?
| | Arkansas | 3 | 2013 | 1978 | 0.040 |
Why?
| | Adipocytes | 1 | 2002 | 126 | 0.040 |
Why?
| | Cell Survival | 1 | 2022 | 588 | 0.040 |
Why?
| | Neurons | 1 | 2022 | 452 | 0.040 |
Why?
| | Proteins | 1 | 2002 | 343 | 0.040 |
Why?
| | Time | 1 | 2018 | 28 | 0.040 |
Why?
| | Ibuprofen | 1 | 2018 | 20 | 0.040 |
Why?
| | United States | 3 | 2018 | 5012 | 0.040 |
Why?
| | Indomethacin | 1 | 2018 | 38 | 0.040 |
Why?
| | Birth Weight | 1 | 2019 | 106 | 0.040 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2018 | 38 | 0.040 |
Why?
| | Infant, Newborn, Diseases | 1 | 2016 | 56 | 0.030 |
Why?
| | Patient Readmission | 1 | 2018 | 229 | 0.030 |
Why?
| | Incidence | 1 | 2018 | 1036 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 902 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 170 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 678 | 0.030 |
Why?
| | Young Adult | 2 | 2016 | 4114 | 0.030 |
Why?
| | Length of Stay | 1 | 2018 | 634 | 0.030 |
Why?
| | Genomics | 1 | 2016 | 279 | 0.030 |
Why?
| | Blood Glucose | 1 | 2016 | 447 | 0.030 |
Why?
| | Risk Assessment | 1 | 2018 | 1271 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2013 | 208 | 0.020 |
Why?
| | Twins, Monozygotic | 1 | 2012 | 15 | 0.020 |
Why?
| | Individuality | 1 | 2012 | 30 | 0.020 |
Why?
| | Patient-Centered Care | 1 | 2013 | 130 | 0.020 |
Why?
| | Myelodysplastic Syndromes | 1 | 2012 | 78 | 0.020 |
Why?
| | Aged | 2 | 2016 | 9770 | 0.020 |
Why?
| | Cerebral Palsy | 1 | 2010 | 38 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2011 | 269 | 0.020 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2010 | 70 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2011 | 584 | 0.020 |
Why?
| | Middle Aged | 2 | 2016 | 12648 | 0.020 |
Why?
| | Adult | 2 | 2016 | 13637 | 0.020 |
Why?
| | Quality of Life | 1 | 2013 | 858 | 0.020 |
Why?
| | Program Evaluation | 1 | 2009 | 352 | 0.020 |
Why?
| | Rural Population | 1 | 2011 | 557 | 0.020 |
Why?
| | Mutation | 1 | 2012 | 1280 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2018 | 6298 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2012 | 3244 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2013 | 5296 | 0.010 |
Why?
| | Leupeptins | 1 | 2002 | 7 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p130 | 1 | 2002 | 8 | 0.010 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2002 | 22 | 0.010 |
Why?
| | Calpain | 1 | 2002 | 25 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 634 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2002 | 238 | 0.010 |
Why?
| | Cell Line | 1 | 2002 | 1001 | 0.010 |
Why?
| | Animals | 1 | 2002 | 13157 | 0.000 |
Why?
|
|
Lyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|